FORMULATION AND EVALUATION OF MEDICATED CHEWING GUM OF DOLASETRON AS AN ANTIEMETIC AGENT
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 4
Abstract
An attempt has been made to formulate new chewing gum for Dolasetron. The new drug delivery system was obtained, at room temperature conventional pharmaceutical equipment. The resulting chewing gum comprises a gum core combined with fillers, antioxidants, coloring agent and plasticizers, which provide smooth appearance and flexibility during storage and chewing. Drug release from a dosage form is the critical step in drug absorption and bioavailability, thus an experimental work has been designed to evaluate the efficiency of this kind of therapeutic system by verifying its capability to release the drug dose and by assessing the delivery of Dolasetron for bypassing the hepatic first pass effect. Simple diffusion into the medium causes the release of only a small percentage of the drug contained in the medicated chewing gum, while the delivery of the major part of the dose occurs during mastication. In the present study, an attempt has been made to formulate the chewing gum of Dolasetron. Different formulations of chewing gum with varying concentration of plasticizers like glycerol and castor oil were formulated. MCG II formulation was considered to be the best-optimized formula which consists of synthetic gum base (45%), Sorbitol (14.6%), sucrose (46%) etc. which shows first slow release the fast release in the phosphate buffer saline (ph 6.8). The cumulative drug release of MCG II formulation was found to be 99.43 %. From this study, we can conclude that the medicated chewing formulation can be a better choice in the coming years which provides several benefits and also benefits commercially.
Authors and Affiliations
Azra Shaikh
Keywords
Related Articles
- EP ID EP293860
- DOI -
- Views 94
- Downloads 0
PHYTOSOME: MOST SIGNIFICANT TOOL FOR HERBAL DRUG DELIVERY TO ENHANCE THE THERAPEUTIC BENEFITS OF PHYTOCONSTITUENTS
Traditional medicinal system relies on the knowledge and clinical expertization of physicians to regulate the indigenous medicinal system for the sake of well being to humans. Considering the bioavailability issues of ph...
AN OVERVIEW OF ANALYTICAL INSTRUMENT QUALIFICATION WITH REFERENCE OF PHARMACEUTICAL INDUSTRY
In the most general sense, validation refers to a process that consists of at least four distinct components or steps: software, instruments, methods or procedures, and system suitability The system, the software, and th...
PROTECTIVE EFFECT OF AQUEOUS EXTRACT POMEGRANATE PEEL AGAINST STERIGMATOCYSTIN TOXICITY IN RAT
ntroduction and Aim: Sterigmatocystin (Stg) a mycotoxin with mutagenic and carcinogenic properties is commonly found as the contaminant in grains and animal feeds. Pomegranate peel is a rich source of antioxidants, flavo...
FORMULATION AND CHARACTERIZATION OF ALLICIN-AMPHOTERICIN-B LIPOSOMAL GEL FOR THE TREATMENT OF FUNGAL INFECTIONS
Spherical multilammelar vesicles of liposome consisting of lipid egg phosphatidylcholine, soya lecithin and cholesterol were prepared by thin film hydration technique. Further liposomal gel was prepared by egg phosphatid...
FABRICATION AND CHARACTERIZATION OF NON STEROIDAL ANTI-INFLAMMATORY ALGINATE BEADS FOR SUSTAINED RELEASE USING NATURAL POLYMER
Extended release formulations are becoming more popular day by day for the delivery of non-steroidal anti-inflammatory drugs (NSAIDs) because of their ability to maintain optimal and therapeutically effective drug levels...